Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PCHM will - over the next 2 Weeks and hit - by . In that time frame, PCHM's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
PCHM shares rose +0.27% in Thursday, August 28, 2025's trading session, rising from a previous close of $3.74 to move at $3.75. The stock demonstrated notable intraday movement (see PCHM's key stats for a full breakdown), fluctuating between $3.74 and $3.75, a +0.27% trading range. While recent weeks have seen some volatility, PCHM has managed to secure a +1.08% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 30.42K shares changing hands, 7.07K fewer than the previous session. This amounted to $114.09K in total market activity.
Will PCHM Continue Its Trend?
According to analyst ratings and projections for PCHM, PharmChem, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PCHM currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the PCHM stock forecast, now is not the best time to buy PCHM stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PCHM covering social and institutional perspectives.
PCHM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PCHM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 56.71% to 78.83%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 55.46%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.31%, maintains a neutral outlook for the long term. Insights into PCHM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

